Literature DB >> 16794383

One thousand consecutive pancreaticoduodenectomies.

John L Cameron1, Taylor S Riall, JoAnn Coleman, Kenneth A Belcher.   

Abstract

OBJECTIVE: To trace the evolution of pancreaticoduodenectomy from the decade of the 1960s through the first decade of the new Millenium, through the experience of one surgeon doing 1000 consecutive operations. SUMMARY BACKGROUND DATA: A regional resection of the head of the pancreas was first performed successfully by Kausch in 1909. The operation was popularized by Whipple in 1935, who reported 3 pancreaticoduodenectomies. Because of a hospital mortality of approximately 25%, the operation was performed infrequently until the 1980s. From the 1980s on, experience with this complex alimentary tract operation increased, and high-volume centers developed. This resulted in a significant drop in hospital mortality and allowed institutions and individuals to gain large experiences.
METHODS: Between March 1969 and May 2003, 1000 consecutive pancreaticoduodenectomies were performed by a single surgeon. A retrospective review of a prospectively maintained database was performed to determine the management and outcome of these patients, as well as to document the evolution of this operative procedure over 5 decades.
RESULTS: The median operative time decreased significantly over the decades, being 8.8 hours in the 1970s and 5.5 hours during the 2000s. Postoperative length of stay dropped from a median of 17 days in the 1980s to 9 days in the 2000s. There were only 10 postoperative/hospital deaths, for a mortality of 1%. A total of 405 patients underwent pancreaticoduodenectomy for adenocarcinoma of the head of the pancreas. Overall 5-year survival was 18%; for the lymph node-negative patients, it was 32%; and for node-negative, margin-negative patients, it was 41%.
CONCLUSIONS: Pancreaticoduodenectomy has become a commonly performed operation in many tertiary care centers. Operative time, blood loss, and length of stay have dropped substantially. The operation has become safe, with a low hospital mortality. It has become an effective operation for pancreatic cancer in those patients in whom their tumor is margin negative and node negative.

Entities:  

Mesh:

Year:  2006        PMID: 16794383      PMCID: PMC1570590          DOI: 10.1097/01.sla.0000217673.04165.ea

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  16 in total

1.  A reminiscence: pancreaticduodenectomy.

Authors:  A O WHIPPLE
Journal:  Rev Surg       Date:  1963 Jul-Aug

2.  TREATMENT OF CARCINOMA OF THE AMPULLA OF VATER.

Authors:  A O Whipple; W B Parsons; C R Mullins
Journal:  Ann Surg       Date:  1935-10       Impact factor: 12.969

3.  The effects of regionalization on cost and outcome for one general high-risk surgical procedure.

Authors:  T A Gordon; G P Burleyson; J M Tielsch; J L Cameron
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

4.  Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality.

Authors:  M Trede; G Schwall; H D Saeger
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

5.  Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial.

Authors:  K D Lillemoe; J L Cameron; J M Hardacre; T A Sohn; P K Sauter; J Coleman; H A Pitt; C J Yeo
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

6.  Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial.

Authors:  Keith D Lillemoe; John L Cameron; Min P Kim; Kurtis A Campbell; Patricia K Sauter; Joann A Coleman; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

7.  A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy.

Authors:  C J Yeo; J L Cameron; M M Maher; P K Sauter; M L Zahurak; M A Talamini; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

8.  Standards for pancreatic resection in the 1990s.

Authors:  C Fernández-del Castillo; D W Rattner; A L Warshaw
Journal:  Arch Surg       Date:  1995-03

9.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

10.  Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy.

Authors:  M D Lieberman; H Kilburn; M Lindsey; M F Brennan
Journal:  Ann Surg       Date:  1995-11       Impact factor: 12.969

View more
  379 in total

Review 1.  Pancreatic surgery: evolution and current tailored approach.

Authors:  Mario Zovak; Dubravka Mužina Mišić; Goran Glavčić
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection.

Authors:  Robert M Cannon; Ryan LeGrand; Ryaz B Chagpar; Syed A Ahmad; Rebecca McClaine; Hong Jin Kim; Christopher Rupp; Cliff S Cho; Adam Brinkman; Sharon Weber; Emily R Winslow; David A Kooby; Carrie K Chu; Charles A Staley; Ian Glenn; William G Hawkins; Alexander A Parikh; Nipun B Merchant; Kelly M McMasters; Robert C G Martin; Glenda G Callender; Charles R Scoggins
Journal:  HPB (Oxford)       Date:  2012-01-19       Impact factor: 3.647

3.  A decision model of therapy for potentially resectable pancreatic cancer.

Authors:  Jacob P VanHouten; Rebekah R White; Gretchen Purcell Jackson
Journal:  J Surg Res       Date:  2011-09-12       Impact factor: 2.192

Review 4.  Fast-track programmes for hepatopancreatic resections: where do we stand?

Authors:  Lidewij Spelt; Daniel Ansari; Christian Sturesson; Bobby Tingstedt; Roland Andersson
Journal:  HPB (Oxford)       Date:  2011-09-26       Impact factor: 3.647

5.  Pancreatectomy risk calculator: an ACS-NSQIP resource.

Authors:  Purvi Parikh; Mira Shiloach; Mark E Cohen; Karl Y Bilimoria; Clifford Y Ko; Bruce L Hall; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2010-09       Impact factor: 3.647

Review 6.  Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review.

Authors:  Terence C Chua; Akshat Saxena
Journal:  J Gastrointest Surg       Date:  2010-04-09       Impact factor: 3.452

7.  Pancreaticoduodenectomy in a Latin American country: the transition to a high-volume center.

Authors:  Carlos Chan; Bernardo Franssen; Alethia Rubio; Luis Uscanga
Journal:  J Gastrointest Surg       Date:  2007-09-01       Impact factor: 3.452

8.  The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma.

Authors:  Wenchuan Wu; Jin He; John L Cameron; Martin Makary; Kevin Soares; Nita Ahuja; Neda Rezaee; Joseph Herman; Lei Zheng; Daniel Laheru; Michael A Choti; Ralph H Hruban; Timothy M Pawlik; Christopher L Wolfgang; Matthew J Weiss
Journal:  Ann Surg Oncol       Date:  2014-04-26       Impact factor: 5.344

Review 9.  Pancreatic cancer and the FAMMM syndrome.

Authors:  Henry T Lynch; Ramon M Fusaro; Jane F Lynch; Randall Brand
Journal:  Fam Cancer       Date:  2007-11-09       Impact factor: 2.375

Review 10.  Status and future directions in the management of pancreatic cancer: potential impact of nanotechnology.

Authors:  Catherine M Sielaff; Shaker A Mousa
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-02       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.